 | • レポートコード：MRC2Q12-17109 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、セルフリー腫瘍DNA検出の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にセルフリー腫瘍DNA検出のグローバル市場のxxx％を占める「液滴デジタルポリメラーゼ連鎖反応」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「乳癌」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 セルフリー腫瘍DNA検出の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのセルフリー腫瘍DNA検出市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 セルフリー腫瘍DNA検出のグローバル主要プレイヤーには、Biocept Inc.、Bio-Rad Laboratories Inc.、Fluxion Biosciences Inc.、F. Hoffmann-La Roche AG、Sysmex Europe SE、Qiagen、NeoGenomics Laboratories Inc.、Menarini Silicon Biosystems、Illumina Inc.、Guardant Health Inc.、Shanghai Biotecan Medical Diagnostics Co.,Ltd.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 セルフリー腫瘍DNA検出市場は、種類と用途によって区分されます。世界のセルフリー腫瘍DNA検出市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 液滴デジタルポリメラーゼ連鎖反応、タグ付きアンプリコンディープシーケンシング、その他 【用途別セグメント】 乳癌、胃癌、肝臓癌、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - セルフリー腫瘍DNA検出製品概要 - 種類別市場（液滴デジタルポリメラーゼ連鎖反応、タグ付きアンプリコンディープシーケンシング、その他） - 用途別市場（乳癌、胃癌、肝臓癌、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のセルフリー腫瘍DNA検出販売量予測2017-2028 - 世界のセルフリー腫瘍DNA検出売上予測2017-2028 - セルフリー腫瘍DNA検出の地域別販売量 - セルフリー腫瘍DNA検出の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別セルフリー腫瘍DNA検出販売量 - 主要メーカー別セルフリー腫瘍DNA検出売上 - 主要メーカー別セルフリー腫瘍DNA検出価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（液滴デジタルポリメラーゼ連鎖反応、タグ付きアンプリコンディープシーケンシング、その他） - セルフリー腫瘍DNA検出の種類別販売量 - セルフリー腫瘍DNA検出の種類別売上 - セルフリー腫瘍DNA検出の種類別価格 ・用途別市場規模（乳癌、胃癌、肝臓癌、その他） - セルフリー腫瘍DNA検出の用途別販売量 - セルフリー腫瘍DNA検出の用途別売上 - セルフリー腫瘍DNA検出の用途別価格 ・北米市場 - 北米のセルフリー腫瘍DNA検出市場規模（種類別、用途別） - 主要国別のセルフリー腫瘍DNA検出市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのセルフリー腫瘍DNA検出市場規模（種類別、用途別） - 主要国別のセルフリー腫瘍DNA検出市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のセルフリー腫瘍DNA検出市場規模（種類別、用途別） - 主要国別のセルフリー腫瘍DNA検出市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のセルフリー腫瘍DNA検出市場規模（種類別、用途別） - 主要国別のセルフリー腫瘍DNA検出市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのセルフリー腫瘍DNA検出市場規模（種類別、用途別） - 主要国別のセルフリー腫瘍DNA検出市場規模（トルコ、サウジアラビア） ・企業情報 Biocept Inc.、Bio-Rad Laboratories Inc.、Fluxion Biosciences Inc.、F. Hoffmann-La Roche AG、Sysmex Europe SE、Qiagen、NeoGenomics Laboratories Inc.、Menarini Silicon Biosystems、Illumina Inc.、Guardant Health Inc.、Shanghai Biotecan Medical Diagnostics Co.,Ltd. ・産業チェーン及び販売チャネル分析 - セルフリー腫瘍DNA検出の産業チェーン分析 - セルフリー腫瘍DNA検出の原材料 - セルフリー腫瘍DNA検出の生産プロセス - セルフリー腫瘍DNA検出の販売及びマーケティング - セルフリー腫瘍DNA検出の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - セルフリー腫瘍DNA検出の産業動向 - セルフリー腫瘍DNA検出のマーケットドライバー - セルフリー腫瘍DNA検出の課題 - セルフリー腫瘍DNA検出の阻害要因 ・主な調査結果 |
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called “liquid biopsy”. ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cell-free Tumor DNA Detection estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cell-free Tumor DNA Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cell-free Tumor DNA Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cell-free Tumor DNA Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Cell-free Tumor DNA Detection include Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems and Illumina Inc., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cell-free Tumor DNA Detection companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cell-free Tumor DNA Detection market. Further, it explains the major drivers and regional dynamics of the global Cell-free Tumor DNA Detection market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Biocept Inc.
Bio-Rad Laboratories Inc.
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen
NeoGenomics Laboratories Inc.
Menarini Silicon Biosystems
Illumina Inc.
Guardant Health Inc.
Shanghai Biotecan Medical Diagnostics Co.,Ltd.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Cell-free Tumor DNA Detection Segment by Type
Droplet Digital Polymerase Chain Reaction
Tagged-Amplicon Deep Sequencing
Others
Cell-free Tumor DNA Detection Segment by Application
Breast Cancer
Stomach Cancer
Liver Cancer
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cell-free Tumor DNA Detection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cell-free Tumor DNA Detection market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cell-free Tumor DNA Detection, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cell-free Tumor DNA Detection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cell-free Tumor DNA Detection revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cell-free Tumor DNA Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cell-free Tumor DNA Detection revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE, Qiagen, NeoGenomics Laboratories Inc., Menarini Silicon Biosystems and Illumina Inc., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cell-free Tumor DNA Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-free Tumor DNA Detection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell-free Tumor DNA Detection revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-free Tumor DNA Detection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Droplet Digital Polymerase Chain Reaction
1.2.3 Tagged-Amplicon Deep Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cell-free Tumor DNA Detection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Liver Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell-free Tumor DNA Detection Market Perspective (2017-2028)
2.2 Cell-free Tumor DNA Detection Growth Trends by Region
2.2.1 Cell-free Tumor DNA Detection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell-free Tumor DNA Detection Historic Market Size by Region (2017-2022)
2.2.3 Cell-free Tumor DNA Detection Forecasted Market Size by Region (2023-2028)
2.3 Cell-free Tumor DNA Detection Market Dynamics
2.3.1 Cell-free Tumor DNA Detection Industry Trends
2.3.2 Cell-free Tumor DNA Detection Market Drivers
2.3.3 Cell-free Tumor DNA Detection Market Challenges
2.3.4 Cell-free Tumor DNA Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-free Tumor DNA Detection Players by Revenue
3.1.1 Global Top Cell-free Tumor DNA Detection Players by Revenue (2017-2022)
3.1.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Players (2017-2022)
3.2 Global Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-free Tumor DNA Detection Revenue
3.4 Global Cell-free Tumor DNA Detection Market Concentration Ratio
3.4.1 Global Cell-free Tumor DNA Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-free Tumor DNA Detection Revenue in 2021
3.5 Cell-free Tumor DNA Detection Key Players Head office and Area Served
3.6 Key Players Cell-free Tumor DNA Detection Product Solution and Service
3.7 Date of Enter into Cell-free Tumor DNA Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-free Tumor DNA Detection Breakdown Data by Type
4.1 Global Cell-free Tumor DNA Detection Historic Market Size by Type (2017-2022)
4.2 Global Cell-free Tumor DNA Detection Forecasted Market Size by Type (2023-2028)
5 Cell-free Tumor DNA Detection Breakdown Data by Application
5.1 Global Cell-free Tumor DNA Detection Historic Market Size by Application (2017-2022)
5.2 Global Cell-free Tumor DNA Detection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell-free Tumor DNA Detection Market Size (2017-2028)
6.2 North America Cell-free Tumor DNA Detection Market Size by Type
6.2.1 North America Cell-free Tumor DNA Detection Market Size by Type (2017-2022)
6.2.2 North America Cell-free Tumor DNA Detection Market Size by Type (2023-2028)
6.2.3 North America Cell-free Tumor DNA Detection Market Share by Type (2017-2028)
6.3 North America Cell-free Tumor DNA Detection Market Size by Application
6.3.1 North America Cell-free Tumor DNA Detection Market Size by Application (2017-2022)
6.3.2 North America Cell-free Tumor DNA Detection Market Size by Application (2023-2028)
6.3.3 North America Cell-free Tumor DNA Detection Market Share by Application (2017-2028)
6.4 North America Cell-free Tumor DNA Detection Market Size by Country
6.4.1 North America Cell-free Tumor DNA Detection Market Size by Country (2017-2022)
6.4.2 North America Cell-free Tumor DNA Detection Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell-free Tumor DNA Detection Market Size (2017-2028)
7.2 Europe Cell-free Tumor DNA Detection Market Size by Type
7.2.1 Europe Cell-free Tumor DNA Detection Market Size by Type (2017-2022)
7.2.2 Europe Cell-free Tumor DNA Detection Market Size by Type (2023-2028)
7.2.3 Europe Cell-free Tumor DNA Detection Market Share by Type (2017-2028)
7.3 Europe Cell-free Tumor DNA Detection Market Size by Application
7.3.1 Europe Cell-free Tumor DNA Detection Market Size by Application (2017-2022)
7.3.2 Europe Cell-free Tumor DNA Detection Market Size by Application (2023-2028)
7.3.3 Europe Cell-free Tumor DNA Detection Market Share by Application (2017-2028)
7.4 Europe Cell-free Tumor DNA Detection Market Size by Country
7.4.1 Europe Cell-free Tumor DNA Detection Market Size by Country (2017-2022)
7.4.2 Europe Cell-free Tumor DNA Detection Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-free Tumor DNA Detection Market Size (2017-2028)
8.2 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Type
8.2.1 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell-free Tumor DNA Detection Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Application
8.3.1 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell-free Tumor DNA Detection Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region
8.4.1 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell-free Tumor DNA Detection Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell-free Tumor DNA Detection Market Size (2017-2028)
9.2 Latin America Cell-free Tumor DNA Detection Market Size by Type
9.2.1 Latin America Cell-free Tumor DNA Detection Market Size by Type (2017-2022)
9.2.2 Latin America Cell-free Tumor DNA Detection Market Size by Type (2023-2028)
9.2.3 Latin America Cell-free Tumor DNA Detection Market Share by Type (2017-2028)
9.3 Latin America Cell-free Tumor DNA Detection Market Size by Application
9.3.1 Latin America Cell-free Tumor DNA Detection Market Size by Application (2017-2022)
9.3.2 Latin America Cell-free Tumor DNA Detection Market Size by Application (2023-2028)
9.3.3 Latin America Cell-free Tumor DNA Detection Market Share by Application (2017-2028)
9.4 Latin America Cell-free Tumor DNA Detection Market Size by Country
9.4.1 Latin America Cell-free Tumor DNA Detection Market Size by Country (2017-2022)
9.4.2 Latin America Cell-free Tumor DNA Detection Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-free Tumor DNA Detection Market Size (2017-2028)
10.2 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Type
10.2.1 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell-free Tumor DNA Detection Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Application
10.3.1 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell-free Tumor DNA Detection Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country
10.4.1 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell-free Tumor DNA Detection Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biocept Inc.
11.1.1 Biocept Inc. Company Details
11.1.2 Biocept Inc. Business Overview
11.1.3 Biocept Inc. Cell-free Tumor DNA Detection Introduction
11.1.4 Biocept Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.1.5 Biocept Inc. Recent Developments
11.2 Bio-Rad Laboratories Inc.
11.2.1 Bio-Rad Laboratories Inc. Company Details
11.2.2 Bio-Rad Laboratories Inc. Business Overview
11.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Introduction
11.2.4 Bio-Rad Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.2.5 Bio-Rad Laboratories Inc. Recent Developments
11.3 Fluxion Biosciences Inc.
11.3.1 Fluxion Biosciences Inc. Company Details
11.3.2 Fluxion Biosciences Inc. Business Overview
11.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Introduction
11.3.4 Fluxion Biosciences Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.3.5 Fluxion Biosciences Inc. Recent Developments
11.4 F. Hoffmann-La Roche AG
11.4.1 F. Hoffmann-La Roche AG Company Details
11.4.2 F. Hoffmann-La Roche AG Business Overview
11.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Introduction
11.4.4 F. Hoffmann-La Roche AG Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.4.5 F. Hoffmann-La Roche AG Recent Developments
11.5 Sysmex Europe SE
11.5.1 Sysmex Europe SE Company Details
11.5.2 Sysmex Europe SE Business Overview
11.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Introduction
11.5.4 Sysmex Europe SE Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.5.5 Sysmex Europe SE Recent Developments
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Cell-free Tumor DNA Detection Introduction
11.6.4 Qiagen Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.6.5 Qiagen Recent Developments
11.7 NeoGenomics Laboratories Inc.
11.7.1 NeoGenomics Laboratories Inc. Company Details
11.7.2 NeoGenomics Laboratories Inc. Business Overview
11.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Introduction
11.7.4 NeoGenomics Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.7.5 NeoGenomics Laboratories Inc. Recent Developments
11.8 Menarini Silicon Biosystems
11.8.1 Menarini Silicon Biosystems Company Details
11.8.2 Menarini Silicon Biosystems Business Overview
11.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Introduction
11.8.4 Menarini Silicon Biosystems Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.8.5 Menarini Silicon Biosystems Recent Developments
11.9 Illumina Inc.
11.9.1 Illumina Inc. Company Details
11.9.2 Illumina Inc. Business Overview
11.9.3 Illumina Inc. Cell-free Tumor DNA Detection Introduction
11.9.4 Illumina Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.9.5 Illumina Inc. Recent Developments
11.10 Guardant Health Inc.
11.10.1 Guardant Health Inc. Company Details
11.10.2 Guardant Health Inc. Business Overview
11.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Introduction
11.10.4 Guardant Health Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.10.5 Guardant Health Inc. Recent Developments
11.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
11.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Details
11.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
11.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Introduction
11.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Revenue in Cell-free Tumor DNA Detection Business (2017-2022)
11.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Cell-free Tumor DNA Detection Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Droplet Digital Polymerase Chain Reaction
Table 3. Key Players of Tagged-Amplicon Deep Sequencing
Table 4. Key Players of Others
Table 5. Global Cell-free Tumor DNA Detection Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Cell-free Tumor DNA Detection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cell-free Tumor DNA Detection Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cell-free Tumor DNA Detection Market Share by Region (2017-2022)
Table 9. Global Cell-free Tumor DNA Detection Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cell-free Tumor DNA Detection Market Share by Region (2023-2028)
Table 11. Cell-free Tumor DNA Detection Market Trends
Table 12. Cell-free Tumor DNA Detection Market Drivers
Table 13. Cell-free Tumor DNA Detection Market Challenges
Table 14. Cell-free Tumor DNA Detection Market Restraints
Table 15. Global Cell-free Tumor DNA Detection Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cell-free Tumor DNA Detection Revenue Share by Players (2017-2022)
Table 17. Global Top Cell-free Tumor DNA Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free Tumor DNA Detection as of 2021)
Table 18. Ranking of Global Top Cell-free Tumor DNA Detection Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cell-free Tumor DNA Detection Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell-free Tumor DNA Detection Product Solution and Service
Table 22. Date of Enter into Cell-free Tumor DNA Detection Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell-free Tumor DNA Detection Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cell-free Tumor DNA Detection Revenue Market Share by Type (2017-2022)
Table 26. Global Cell-free Tumor DNA Detection Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cell-free Tumor DNA Detection Revenue Market Share by Type (2023-2028)
Table 28. Global Cell-free Tumor DNA Detection Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cell-free Tumor DNA Detection Revenue Share by Application (2017-2022)
Table 30. Global Cell-free Tumor DNA Detection Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cell-free Tumor DNA Detection Revenue Share by Application (2023-2028)
Table 32. North America Cell-free Tumor DNA Detection Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Cell-free Tumor DNA Detection Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Cell-free Tumor DNA Detection Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Cell-free Tumor DNA Detection Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Cell-free Tumor DNA Detection Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Cell-free Tumor DNA Detection Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Cell-free Tumor DNA Detection Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Cell-free Tumor DNA Detection Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Cell-free Tumor DNA Detection Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Cell-free Tumor DNA Detection Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Cell-free Tumor DNA Detection Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Cell-free Tumor DNA Detection Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Cell-free Tumor DNA Detection Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Cell-free Tumor DNA Detection Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Cell-free Tumor DNA Detection Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Cell-free Tumor DNA Detection Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Cell-free Tumor DNA Detection Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Cell-free Tumor DNA Detection Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Cell-free Tumor DNA Detection Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Cell-free Tumor DNA Detection Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Cell-free Tumor DNA Detection Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Cell-free Tumor DNA Detection Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Cell-free Tumor DNA Detection Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Cell-free Tumor DNA Detection Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Cell-free Tumor DNA Detection Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Cell-free Tumor DNA Detection Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cell-free Tumor DNA Detection Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cell-free Tumor DNA Detection Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Cell-free Tumor DNA Detection Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Cell-free Tumor DNA Detection Market Size by Country (2023-2028) & (US$ Million)
Table 62. Biocept Inc. Company Details
Table 63. Biocept Inc. Business Overview
Table 64. Biocept Inc. Cell-free Tumor DNA Detection Product
Table 65. Biocept Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 66. Biocept Inc. Recent Developments
Table 67. Bio-Rad Laboratories Inc. Company Details
Table 68. Bio-Rad Laboratories Inc. Business Overview
Table 69. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product
Table 70. Bio-Rad Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 71. Bio-Rad Laboratories Inc. Recent Developments
Table 72. Fluxion Biosciences Inc. Company Details
Table 73. Fluxion Biosciences Inc. Business Overview
Table 74. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product
Table 75. Fluxion Biosciences Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 76. Fluxion Biosciences Inc. Recent Developments
Table 77. F. Hoffmann-La Roche AG Company Details
Table 78. F. Hoffmann-La Roche AG Business Overview
Table 79. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product
Table 80. F. Hoffmann-La Roche AG Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 81. F. Hoffmann-La Roche AG Recent Developments
Table 82. Sysmex Europe SE Company Details
Table 83. Sysmex Europe SE Business Overview
Table 84. Sysmex Europe SE Cell-free Tumor DNA Detection Product
Table 85. Sysmex Europe SE Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 86. Sysmex Europe SE Recent Developments
Table 87. Qiagen Company Details
Table 88. Qiagen Business Overview
Table 89. Qiagen Cell-free Tumor DNA Detection Product
Table 90. Qiagen Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 91. Qiagen Recent Developments
Table 92. NeoGenomics Laboratories Inc. Company Details
Table 93. NeoGenomics Laboratories Inc. Business Overview
Table 94. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product
Table 95. NeoGenomics Laboratories Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 96. NeoGenomics Laboratories Inc. Recent Developments
Table 97. Menarini Silicon Biosystems Company Details
Table 98. Menarini Silicon Biosystems Business Overview
Table 99. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product
Table 100. Menarini Silicon Biosystems Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 101. Menarini Silicon Biosystems Recent Developments
Table 102. Illumina Inc. Company Details
Table 103. Illumina Inc. Business Overview
Table 104. Illumina Inc. Cell-free Tumor DNA Detection Product
Table 105. Illumina Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 106. Illumina Inc. Recent Developments
Table 107. Guardant Health Inc. Company Details
Table 108. Guardant Health Inc. Business Overview
Table 109. Guardant Health Inc. Cell-free Tumor DNA Detection Product
Table 110. Guardant Health Inc. Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 111. Guardant Health Inc. Recent Developments
Table 112. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Company Details
Table 113. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
Table 114. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product
Table 115. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Revenue in Cell-free Tumor DNA Detection Business (2017-2022) & (US$ Million)
Table 116. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-free Tumor DNA Detection Market Share by Type: 2021 VS 2028
Figure 2. Droplet Digital Polymerase Chain Reaction Features
Figure 3. Tagged-Amplicon Deep Sequencing Features
Figure 4. Others Features
Figure 5. Global Cell-free Tumor DNA Detection Market Share by Application: 2021 VS 2028
Figure 6. Breast Cancer Case Studies
Figure 7. Stomach Cancer Case Studies
Figure 8. Liver Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Cell-free Tumor DNA Detection Report Years Considered
Figure 11. Global Cell-free Tumor DNA Detection Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cell-free Tumor DNA Detection Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cell-free Tumor DNA Detection Market Share by Region: 2021 VS 2028
Figure 14. Global Cell-free Tumor DNA Detection Market Share by Players in 2021
Figure 15. Global Top Cell-free Tumor DNA Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free Tumor DNA Detection as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cell-free Tumor DNA Detection Revenue in 2021
Figure 17. North America Cell-free Tumor DNA Detection Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
Figure 19. North America Cell-free Tumor DNA Detection Market Size Market Share by Application (2017-2028)
Figure 20. North America Cell-free Tumor DNA Detection Market Size Share by Country (2017-2028)
Figure 21. United States Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Cell-free Tumor DNA Detection Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
Figure 25. Europe Cell-free Tumor DNA Detection Market Size Market Share by Application (2017-2028)
Figure 26. Europe Cell-free Tumor DNA Detection Market Size Share by Country (2017-2028)
Figure 27. Germany Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Cell-free Tumor DNA Detection Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Cell-free Tumor DNA Detection Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Cell-free Tumor DNA Detection Market Size Share by Region (2017-2028)
Figure 37. China Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Cell-free Tumor DNA Detection Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Cell-free Tumor DNA Detection Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Cell-free Tumor DNA Detection Market Size Share by Country (2017-2028)
Figure 47. Mexico Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Cell-free Tumor DNA Detection Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Cell-free Tumor DNA Detection Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Cell-free Tumor DNA Detection Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Cell-free Tumor DNA Detection Market Size Share by Country (2017-2028)
Figure 53. Turkey Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Cell-free Tumor DNA Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Biocept Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 57. Bio-Rad Laboratories Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 58. Fluxion Biosciences Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 59. F. Hoffmann-La Roche AG Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 60. Sysmex Europe SE Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 61. Qiagen Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 62. NeoGenomics Laboratories Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 63. Menarini Silicon Biosystems Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 64. Illumina Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 65. Guardant Health Inc. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 66. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Revenue Growth Rate in Cell-free Tumor DNA Detection Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed